Next Article in Journal
Comparative Analysis of Health Economic Evaluations for Different Influenza Vaccines and Vaccination Strategies in China: A Systematic Review
Next Article in Special Issue
Prevention of Cardiovascular Diseases with Standard-Dose Quadrivalent Influenza Vaccine in People Aged ≥50 Years in Australia During the 2017 A/H3N2 Epidemic
Previous Article in Journal
Exploring CD169+ Macrophages as Key Targets for Vaccination and Therapeutic Interventions
Previous Article in Special Issue
Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Article

Article Versions Notes

Vaccines 2025, 13(3), 331; https://doi.org/10.3390/vaccines13030331
Action Date Notes Link
article xml file uploaded 20 March 2025 09:12 CET Original file -
article xml uploaded. 20 March 2025 09:12 CET Update https://www.mdpi.com/2076-393X/13/3/331/xml
article pdf uploaded. 20 March 2025 09:12 CET Version of Record https://www.mdpi.com/2076-393X/13/3/331/pdf
article supplementary file uploaded. 20 March 2025 09:12 CET - https://www.mdpi.com/2076-393X/13/3/331#supplementary
article html file updated 20 March 2025 09:14 CET Original file https://www.mdpi.com/2076-393X/13/3/331/html
Back to TopTop